S. Abboud and D. J. Haile, A novel mammalian iron-regulated protein involved in intracellular iron metabolism, J. Biol. Chem, vol.275, pp.19906-19912, 2000.

J. Adolfsson, R. Månsson, N. Buza-vidas, A. Hultquist, K. Liuba et al., Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment, Cell, vol.121, pp.295-306, 2005.

A. Aguilera and T. García-muse, R Loops: From Transcription Byproducts to Threats to Genome Stability, Molecular Cell, vol.46, pp.115-124, 2012.

R. Allikmets, W. H. Raskind, A. Hutchinson, N. D. Schueck, M. Dean et al., Mutation of a Putative Mitochondrial Iron Transporter Gene (ABC7) in X-Linked Sideroblastic Anemia and Ataxia (XLSA/A), Hum Mol Genet, vol.8, pp.743-749, 1999.

S. Alsafadi, A. Houy, A. Battistella, T. Popova, M. Wassef et al., Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage, Nature Communications, vol.7, p.10615, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01272099

I. Ambaglio, L. Malcovati, E. Papaemmanuil, C. M. Laarakkers, M. G. Porta et al., Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1, Haematologica, vol.98, pp.420-423, 2013.

J. D. Amigo, M. Yu, M. Troadec, B. Gwynn, J. D. Cooney et al., Identification of distal cis-regulatory elements at mouse mitoferrin loci using zebrafish transgenesis, Mol. Cell. Biol, vol.31, pp.1344-1356, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01120680

X. An, V. P. Schulz, J. Li, K. Wu, J. Liu et al., , 2014.

, Global transcriptome analyses of human and murine terminal erythroid differentiation, Blood, vol.123, pp.3466-3477

E. Anguita, J. Hughes, C. Heyworth, G. A. Blobel, W. G. Wood et al., Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2, EMBO J, vol.23, pp.2841-2852, 2004.

D. A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M. J. Borowitz et al., The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia, Blood, vol.127, pp.2391-2405, 2016.

J. Arezes, N. Foy, K. Mchugh, A. Sawant, D. Quinkert et al., Erythroferrone inhibits the induction of hepcidin by BMP6, 2018.

S. Aschemeyer, B. Qiao, D. Stefanova, E. V. Valore, A. C. Sek et al., Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin, Blood, vol.131, pp.899-910, 2018.

D. R. Ashby, D. P. Gale, M. Busbridge, K. G. Murphy, N. D. Duncan et al., Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin, Haematologica, vol.95, pp.505-508, 2010.

C. Aul, M. Arning, V. Runde, and W. Schneider, Serum erythropoietin concentrations in patients with myelodysplastic syndromes, Leukemia Research, vol.15, pp.571-575, 1991.

W. R. Austin, A. L. Armijo, D. O. Campbell, A. S. Singh, T. Hsieh et al., Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress, J. Exp. Med, vol.209, pp.2215-2228, 2012.

J. L. Babitt, F. W. Huang, D. M. Wrighting, Y. Xia, Y. Sidis et al., Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression, Nature Genetics, vol.38, pp.531-539, 2006.

J. L. Babitt, F. W. Huang, Y. Xia, Y. Sidis, N. C. Andrews et al., Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance, J Clin Invest, vol.117, pp.1933-1939, 2007.

D. Z. De-back, E. B. Kostova, M. Van-kraaij, . Van-den, T. K. Berg et al., Of macrophages and red blood cells; a complex love story, Front Physiol, vol.5, 2014.

S. Bandyopadhyay, F. Gama, M. M. Molina-navarro, J. M. Gualberto, R. Claxton et al., Chloroplast monothiol glutaredoxins as scaffold proteins for the assembly and delivery of, EMBO J, vol.27, pp.1122-1133, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01332174

M. H. Baron, J. Isern, and S. T. Fraser, The embryonic origins of erythropoiesis in mammals, Blood, vol.119, pp.4828-4837, 2012.

S. M. Berget, C. Moore, and P. A. Sharp, Spliced segments at the 5' terminus of adenovirus 2 late mRNA, Proc. Natl. Acad. Sci. U.S.A, vol.74, pp.3171-3175, 1977.

M. C. Bessis and J. Breton-gorius, Iron Metabolism in the Bone Marrow as Seen by Electron Microscopy: A Critical Review, Blood, vol.19, pp.635-663, 1962.

C. Besson-fournier, C. Latour, L. Kautz, J. Bertrand, T. Ganz et al., Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling, Blood, vol.120, pp.431-439, 2012.

S. Bessonov, M. Anokhina, A. Krasauskas, M. M. Golas, B. Sander et al., Characterization of purified human Bact spliceosomal complexes reveals compositional and morphological changes during spliceosome activation and first step catalysis, RNA, vol.16, pp.2384-2403, 2010.

A. L. Beyer and Y. N. Osheim, Splice site selection, rate of splicing, and alternative splicing on nascent transcripts, Genes Dev, vol.2, pp.754-765, 1988.

A. V. Biankin, N. Waddell, K. S. Kassahn, M. Gingras, L. B. Muthuswamy et al., Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes, Nature, vol.491, pp.399-405, 2012.

S. Bonnal, L. Vigevani, and J. Valcárcel, The spliceosome as a target of novel antitumour drugs, Nature Reviews Drug Discovery, vol.11, pp.847-859, 2012.

A. Boudrez, M. Beullens, E. Waelkens, W. Stalmans, and M. Bollen, Phosphorylationdependent Interaction between the Splicing Factors SAP155 and NIPP1, J. Biol. Chem, vol.277, pp.31834-31841, 2002.

J. Boultwood, A. Pellagatti, M. Nikpour, B. Pushkaran, C. Fidler et al., The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts, PLoS ONE, vol.3, 1970.

S. J. Brada, J. T. Wolf, . De, D. Hendriks, H. Louwes et al., Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor, Leukemia, vol.12, pp.340-345, 1998.

P. Brissot, M. Ropert, C. Le-lan, and O. Loréal, Non-transferrin bound iron: a key role in iron overload and iron toxicity, Biochim. Biophys. Acta, vol.1820, pp.403-410, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00739430

V. C. Broudy, Stem Cell Factor and Hematopoiesis, Blood, vol.90, pp.1345-1364, 1997.

V. C. Broudy, N. Lin, M. Brice, B. Nakamoto, and T. Papayannopoulou, Erythropoietin receptor characteristics on primary human erythroid cells, Blood, vol.77, pp.2583-2590, 1991.

C. B. Burge, R. A. Padgett, and P. A. Sharp, Evolutionary fates and origins of U12-type introns, Mol. Cell, vol.2, pp.773-785, 1998.

S. Burma, B. P. Chen, M. Murphy, A. Kurimasa, C. et al., ATM phosphorylates histone H2AX in response to DNA double-strand breaks, J. Biol. Chem, vol.276, pp.42462-42467, 2001.

C. Camaschella, A. Campanella, L. De-falco, L. Boschetto, R. Merlini et al., The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload, Blood, vol.110, pp.1353-1358, 2007.

S. Canali, K. B. Zumbrennen-bullough, A. B. Core, C. Wang, M. Nairz et al., Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice, Blood, vol.129, pp.405-414, 2017.

F. Canonne-hergaux, S. Gruenheid, P. Ponka, and P. Gros, Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron, Blood, vol.93, pp.4406-4417, 1999.

G. Casanovas, M. Vuji?-spasic, C. Casu, S. Rivella, J. Strelau et al., The murine growth differentiation factor 15 is not essential for systemic iron homeostasis in phlebotomized mice, Haematologica, vol.98, pp.444-447, 2013.

J. L. Casey, D. M. Koeller, V. C. Ramin, R. D. Klausner, and J. B. Harford, Iron regulation of transferrin receptor mRNA levels requires iron-responsive elements and a rapid turnover determinant in the 3' untranslated region of the mRNA, EMBO J, vol.8, pp.3693-3699, 1989.

C. Bosch, P. Segura-bayona, S. Koole, W. Van-heteren, J. T. Dewar et al., FANCJ promotes DNA synthesis through G-quadruplex structures, EMBO J, vol.33, pp.2521-2533, 2014.

J. S. Caudill, H. Imran, J. C. Porcher, and D. P. Steensma, Congenital sideroblastic anemia associated with germline polymorphisms reducing expression of FECH, Haematologica, vol.93, pp.1582-1584, 2008.

M. Cazzola, G. Barosi, P. G. Gobbi, R. Invernizzi, A. Riccardi et al., Natural history of idiopathic refractory sideroblastic anemia, Blood, vol.71, pp.305-312, 1988.

S. M. Cerritelli and R. J. Crouch, Ribonuclease H: the enzymes in eukaryotes, FEBS J, vol.276, pp.1494-1505, 2009.

J. H. Chan, S. Lim, and W. S. Wong, Antisense oligonucleotides: from design to therapeutic application, Clin. Exp. Pharmacol. Physiol, vol.33, pp.533-540, 2006.

A. De-la-chapelle, A. L. Träskelin, J. , and E. , Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis, Proc. Natl. Acad. Sci. U.S.A, vol.90, pp.4495-4499, 1993.

L. Chen, J. Chen, X. Zhang, Y. Gu, R. Xiao et al.,

R. , Using Inactive RNase H Reveals Dynamic Coupling of R-loops with Transcriptional Pausing at Gene Promoters, Mol. Cell, vol.68, pp.745-757

L. Chen, J. Chen, Y. Huang, Y. Gu, J. Qiu et al.,

, The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations, Mol. Cell, vol.69, pp.412-425

T. H. Chen, .. Kambal, A. Krysiak, K. Walshauser, M. A. Raju et al., Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice, Blood, vol.117, pp.1530-1539, 2011.

V. Chesnais, A. Renneville, A. Toma, J. Lambert, M. Passet et al., Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion, Blood, vol.127, pp.749-760, 2016.

V. Chesnais, M. Arcangeli, C. Delette, A. Rousseau, H. Guermouche et al., Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes, Blood, vol.129, pp.484-496, 2017.

S. T. Chou, E. Khandros, L. C. Bailey, K. E. Nichols, C. R. Vakoc et al., Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate, Blood, vol.114, pp.983-994, 2009.

L. T. Chow, R. E. Gelinas, T. R. Broker, and R. J. Roberts, An amazing sequence arrangement at the 5' ends of adenovirus 2 messenger, RNA. Cell, vol.12, pp.1-8, 1977.

Y. Claessens, D. Bouscary, J. Dupont, F. Picard, J. Melle et al., In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis, Blood, vol.99, pp.1594-1601, 2002.

A. R. Collins, Oxidative DNA damage, antioxidants, and cancer, BioEssays, vol.21, pp.238-246, 1999.

J. G. Conboy, RNA splicing during terminal erythropoiesis, Curr. Opin. Hematol, vol.24, pp.215-221, 2017.

A. Cortelezzi, C. Cattaneo, S. Cristiani, L. Duca, B. Sarina et al., Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?, Hematol. J, vol.1, pp.153-158, 2000.

D. Cortez, G. Glick, and S. J. Elledge, Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases, PNAS, vol.101, pp.10078-10083, 2004.

A. Corvelo, M. Hallegger, C. W. Smith, and E. Eyras, Genome-Wide Association between Branch Point Properties and Alternative Splicing, PLOS Computational Biology, vol.6, 2010.

C. Cretu, J. Schmitzová, A. Ponce-salvatierra, O. Dybkov, E. I. De-laurentiis et al., Molecular Architecture of SF3b and Structural Consequences of Its Cancer-Related Mutations, Molecular Cell, vol.64, pp.307-319, 2016.

P. Csere, R. Lill, and G. Kispal, Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p, FEBS Lett, vol.441, pp.266-270, 1998.

R. Cui, R. P. Gale, G. Zhu, Z. Xu, T. Qin et al., Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions, Leukemia Research, vol.38, pp.545-550, 2014.

F. Damm, O. Kosmider, V. Gelsi-boyer, A. Renneville, N. Carbuccia et al., Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes, Blood, vol.119, pp.3211-3218, 2012.

R. B. Darman, M. Seiler, A. A. Agrawal, K. H. Lim, S. Peng et al., Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3? Splice Site Selection through Use of a Different Branch Point, Cell Reports, vol.13, pp.1033-1045, 2015.

A. A. Davies, D. Huttner, Y. Daigaku, S. Chen, and H. D. Ulrich, Activation of ubiquitindependent DNA damage bypass is mediated by replication protein a, Mol. Cell, vol.29, pp.625-636, 2008.

R. De-maria, A. Zeuner, A. Eramo, C. Domenichelli, D. Bonci et al., Negative regulation of erythropoiesis by caspasemediated cleavage of GATA-1, Nature, vol.401, pp.489-493, 1999.

C. Deboever, E. M. Ghia, P. J. Shepard, L. Rassenti, C. L. Barrett et al., Transcriptome Sequencing Reveals Potential Mechanism of Cryptic 3' Splice Site Selection in SF3B1-mutated Cancers, PLoS Comput Biol, vol.11, 2015.

F. Desmet, D. Hamroun, M. Lalande, G. Collod-béroud, M. Claustres et al., , 2009.

, Human Splicing Finder: an online bioinformatics tool to predict splicing signals, Nucleic Acids Res, vol.37, pp.67-67

H. Dolatshad, A. Pellagatti, M. Fernandez-mercado, B. H. Yip, L. Malcovati et al., Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells, Leukemia, vol.29, p.1798, 2015.

H. Dolatshad, A. Pellagatti, F. G. Liberante, M. Llorian, E. Repapi et al., Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes, Leukemia, vol.30, pp.2322-2331, 2016.

A. Donovan, A. Brownlie, Y. Zhou, J. Shepard, S. J. Pratt et al., Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter, Nature, vol.403, pp.776-781, 2000.

M. Donzelli and G. F. Draetta, Regulating mammalian checkpoints through Cdc25 inactivation, EMBO Rep, vol.4, pp.671-677, 2003.

V. Duli?, W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees et al., p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest, Cell, vol.76, pp.1013-1023, 1994.

M. Dussiot, T. T. Maciel, A. Fricot, C. Chartier, O. Negre et al., An activin receptor IIA ligand trap corrects ineffective erythropoiesis in ?-thalassemia, Nature Medicine, vol.20, pp.398-407, 2014.

P. G. Ekert, J. Silke, and D. L. Vaux, Caspase inhibitors, Cell Death Differ, vol.6, pp.1081-1086, 1999.

S. Fakan, Perichromatin fibrils are in situ forms of nascent transcripts, Trends Cell Biol, vol.4, pp.86-90, 1994.

L. Fan, C. Lagisetti, C. C. Edwards, T. R. Webb, and P. M. Potter, Sudemycins, Novel Small Molecule Analogues of FR901464, Induce Alternative Gene Splicing, ACS Chemical Biology, vol.6, pp.582-589, 2011.

N. Felli, F. Pedini, A. Zeuner, E. Petrucci, U. Testa et al., Multiple members of the TNF superfamily contribute to IFNgamma-mediated inhibition of erythropoiesis, J. Immunol, vol.175, pp.1464-1472, 2005.

P. Fenaux, A. , and L. , How we treat lower-risk myelodysplastic syndromes, Blood, vol.121, pp.4280-4286, 2013.

C. Finger, C. Escher, and D. Schneider, The single transmembrane domains of human receptor tyrosine kinases encode self-interactions, Sci Signal, vol.2, p.56, 2009.

J. Flach, S. T. Bakker, M. Mohrin, P. C. Conroy, E. M. Pietras et al., Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells, Nature, vol.512, pp.198-202, 2014.

J. G. Flanagan, D. C. Chan, and P. Leder, Transmembrane Form of the kit Ligand Growth Factor Is Determined by Alternative Splicing and Is Missing in the Nd Mutant, vol.11

M. D. Fleming, M. A. Romano, M. A. Su, L. M. Garrick, M. D. Garrick et al., , 1998.

, Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.1148-1153

M. Fontenay-roupie, D. Bouscary, M. Guesnu, F. Picard, J. Melle et al., Ineffective erythropoiesis in myelodysplastic syndromes: correlation with Fas expression but not with lack of erythropoietin receptor signal transduction, Br. J. Haematol, vol.106, pp.464-473, 1999.

R. Freire, M. A. Van-vugt, I. Mamely, and R. Medema, Claspin: Timing the Cell Cycle Arrest When the Genome is Damaged, Cell Cycle, vol.5, pp.2831-2834, 2006.

E. Frisan, J. Vandekerckhove, A. De-thonel, C. Pierre-eugène, A. Sternberg et al., Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes, Blood, vol.119, pp.1532-1542, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00665533

X. Fu, Exploiting the Hidden Treasure of Detained Introns, Cancer Cell, vol.32, pp.393-395, 2017.

Y. Fujiwara, C. P. Browne, K. Cunniff, S. C. Goff, and S. H. Orkin, Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1, Proc. Natl. Acad. Sci. U.S.A, vol.93, pp.12355-12358, 1996.

R. Furumai, K. Uchida, Y. Komi, M. Yoneyama, K. Ishigami et al., Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF, Cancer Sci, vol.101, pp.2483-2489, 2010.

H. Gaillard, T. García-muse, and A. Aguilera, Replication stress and cancer, Nat. Rev. Cancer, vol.15, pp.276-289, 2015.

T. Ganz, G. Jung, A. Naeim, Y. Ginzburg, Z. Pakbaz et al., Immunoassay for human serum erythroferrone, Blood, vol.130, pp.1243-1246, 2017.

S. García-gómez, A. Reyes, M. I. Martínez-jiménez, E. S. Chocrón, S. Mourón et al., PrimPol, an archaic primase/polymerase operating in human cells, Mol. Cell, vol.52, pp.541-553, 2013.

S. Gardenghi, P. Ramos, M. F. Marongiu, L. Melchiori, L. Breda et al., Hepcidin as a therapeutic tool to limit iron overload and improve anemia in ?-thalassemic mice, J Clin Invest, vol.120, pp.4466-4477, 2010.

N. Gattermann, C. Finelli, M. D. Porta, P. Fenaux, M. Stadler et al., Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes, Haematologica, vol.97, pp.1364-1371, 2012.

E. Gautier, S. Ducamp, M. Leduc, V. Salnot, F. Guillonneau et al., Comprehensive Proteomic Analysis of Human Erythropoiesis, Cell Rep, vol.16, pp.1470-1484, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01356018

X. Q. Ge and J. J. Blow, Chk1 inhibits replication factory activation but allows dormant origin firing in existing factories, The Journal of Cell Biology, vol.191, pp.1285-1297, 2010.

G. Genovese, A. K. Kähler, R. E. Handsaker, J. Lindberg, S. A. Rose et al., Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence, New England Journal of Medicine, vol.371, pp.2477-2487, 2014.

D. Gentien, O. Kosmider, F. Nguyen-khac, B. Albaud, A. Rapinat et al., A common alternative splicing signature is associated with SF3B1 mutations in malignancies from different cell lineages, Leukemia, vol.28, pp.1355-1357, 2014.

M. Gerstung, A. Pellagatti, L. Malcovati, A. Giagounidis, M. G. Porta et al., Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes, Nat Commun, vol.6, p.5901, 2015.

C. Girard, C. L. Will, J. Peng, E. M. Makarov, B. Kastner et al., Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion, Nature Communications, vol.3, p.994, 2012.

S. Gobert, V. Duprez, C. Lacombe, S. Gisselbrecht, and P. Mayeux, The signal transduction pathway of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7 erythroleukemia cells, Eur. J. Biochem, vol.234, pp.75-83, 1995.

V. G. Gorgoulis, L. F. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas et al., Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions, Nature, vol.434, pp.907-913, 2005.

T. Goswami and N. C. Andrews, Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing, J. Biol. Chem, vol.281, pp.28494-28498, 2006.

O. Gozani, J. Potashkin, and R. Reed, A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site, Mol. Cell. Biol, vol.18, pp.4752-4760, 1998.

K. De-graaf, H. Czajkowska, S. Rottmann, L. C. Packman, R. Lilischkis et al., The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site, BMC Biochem, vol.7, p.7, 2006.

T. A. Graubert, D. Shen, L. Ding, T. Okeyo-owuor, C. L. Lunn et al., Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes, Nat. Genet, vol.44, pp.53-57, 2011.

P. Greenberg, C. Cox, M. M. Lebeau, P. Fenaux, P. Morel et al., International scoring system for evaluating prognosis in myelodysplastic syndromes, Blood, vol.89, pp.2079-2088, 1997.

P. L. Greenberg, H. Tuechler, J. Schanz, G. Sanz, G. Garcia-manero et al., Revised International Prognostic Scoring System for Myelodysplastic Syndromes, Blood, vol.120, pp.2454-2465, 2012.

T. Gregory, C. Yu, A. Ma, S. H. Orkin, G. A. Blobel et al., GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression, Blood, vol.94, pp.87-96, 1999.

M. R. Groves, N. Hanlon, P. Turowski, B. A. Hemmings, and D. Barford, The Structure of the Protein Phosphatase 2A PR65/A Subunit Reveals the Conformation of Its 15 Tandemly Repeated HEAT Motifs, Cell, vol.96, pp.99-110, 1999.

D. L. Guernsey, H. Jiang, D. R. Campagna, S. C. Evans, M. Ferguson et al., Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia, Nat. Genet, vol.41, pp.651-653, 2009.

T. A. Guilliam, N. C. Brissett, A. Ehlinger, B. A. Keen, P. Kolesar et al., Molecular basis for PrimPol recruitment to replication forks by RPA, Nature Communications, vol.8, p.15222, 2017.

H. Gunshin, B. Mackenzie, U. V. Berger, Y. Gunshin, M. F. Romero et al., Cloning and characterization of a mammalian proton-coupled metal-ion transporter, Nature, vol.388, pp.482-488, 1997.

E. Gyan, E. Frisan, O. Beyne-rauzy, J. Deschemin, C. Pierre-eugene et al., Spontaneous and Fasinduced apoptosis of low-grade MDS erythroid precursors involves the endoplasmic reticulum, Leukemia, vol.22, pp.1864-1873, 2008.

D. J. Haile, T. A. Rouault, C. K. Tang, J. Chin, J. B. Harford et al., Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster, Proc. Natl. Acad. Sci. U.S.A, vol.89, pp.7536-7540, 1992.

K. Hanada, M. Budzowska, S. L. Davies, E. Van-drunen, H. Onizawa et al., The structure-specific endonuclease Mus81 contributes to replication restart by generating double-strand DNA breaks, Nature Structural & Molecular Biology, vol.14, pp.1096-1104, 2007.

M. Hanspal, Y. Smockova, and Q. Uong, Molecular identification and functional characterization of a novel protein that mediates the attachment of erythroblasts to macrophages, Blood, vol.92, pp.2940-2950, 1998.

P. M. Harrison, F. A. Fischbach, T. G. Hoy, and G. H. Haggis, Ferric oxyhydroxide core of ferritin, Nature, vol.216, pp.1188-1190, 1967.

S. R. Hartono, A. Malapert, P. Legros, P. Bernard, F. Chédin et al., The Affinity of the S9.6 Antibody for Double-Stranded RNAs Impacts the Accurate Mapping of R-Loops in Fission Yeast, J. Mol. Biol, vol.430, pp.272-284, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02347226

M. C. Heinrich, D. C. Dooley, A. C. Freed, L. Band, M. E. Hoatlin et al., Constitutive expression of steel factor gene by human stromal cells, Blood, vol.82, pp.771-783, 1993.

S. K. Horrigan, Z. H. Arbieva, H. Y. Xie, J. Kravarusic, N. C. Fulton et al., Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31, Blood, vol.95, pp.2372-2377, 2000.

J. Hu, J. Liu, F. Xue, G. Halverson, M. Reid et al., Isolation and functional characterization of human erythroblasts at distinct stages: implications for understanding of normal and disordered erythropoiesis in vivo, Blood, vol.121, pp.3246-3253, 2013.

Y. Huang, J. Hale, Y. Wang, W. Li, S. Zhang et al., SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS, J Hematol Oncol, vol.11, 2018.

N. Hubert and M. W. Hentze, Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.12345-12350, 2002.

N. Hustedt and D. Durocher, The control of DNA repair by the cell cycle, Nat. Cell Biol, vol.19, pp.1-9, 2016.

J. O. Ilagan, A. Ramakrishnan, B. Hayes, M. E. Murphy, A. S. Zebari et al., U2AF1 mutations alter splice site recognition in hematological malignancies, Genome Research, vol.25, pp.14-26, 2015.

M. Ishiai, H. Kitao, A. Smogorzewska, J. Tomida, A. Kinomura et al., FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway, Nat. Struct. Mol. Biol, vol.15, pp.1138-1146, 2008.

K. Isono, Mammalian Polycomb-mediated repression of Hox genes requires the essential spliceosomal protein Sf3b1, Genes & Development, vol.19, pp.536-541, 2005.

E. Jabbour, H. M. Kantarjian, C. Koller, and A. Taher, Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes, Cancer, vol.112, pp.1089-1095, 2008.

S. Jaiswal, P. Fontanillas, J. Flannick, A. Manning, P. V. Grauman et al., Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes, New England Journal of Medicine, vol.371, pp.2488-2498, 2014.

J. L. Jenkins and C. L. Kielkopf, Splicing Factor Mutations in Myelodysplasias: Insights from Spliceosome Structures, Trends in Genetics, vol.33, pp.336-348, 2017.

P. Ji, V. Yeh, T. Ramirez, M. Murata-hori, and H. F. Lodish, Histone deacetylase 2 is required for chromatin condensation and subsequent enucleation of cultured mouse fetal erythroblasts, Haematologica, vol.95, pp.2013-2021, 2010.

X. Ji, Y. Zhou, S. Pandit, J. Huang, H. Li et al., , 2013.

, SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase, Cell, vol.153, pp.855-868

P. Joshi, S. Halene, and O. Wahab, How do messenger RNA splicing alterations drive myelodysplasia?, Blood, vol.129, pp.2465-2470, 2017.

A. Kahles, K. Lehmann, N. C. Toussaint, M. Hüser, S. G. Stark et al., Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients, Cancer Cell, vol.34, pp.211-224, 2018.

D. Kaida, H. Motoyoshi, E. Tashiro, T. Nojima, M. Hagiwara et al., Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA, Nature Chemical Biology, vol.3, pp.576-583, 2007.

L. Kautz, , 2014.

, Med Sci, vol.30, pp.834-836

L. Kautz, G. Jung, E. V. Valore, S. Rivella, E. Nemeth et al., Identification of erythroferrone as an erythroid regulator of iron metabolism, Nature Genetics, vol.46, pp.678-684, 2014.

G. Kavanaugh, F. Ye, K. N. Mohni, J. W. Luzwick, G. Glick et al., A whole genome RNAi screen identifies replication stress response genes, DNA Repair (Amst.), vol.35, pp.55-62, 2015.

H. Kawabata, R. Yang, T. Hirama, P. T. Vuong, S. Kawano et al., Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family, J. Biol. Chem, vol.274, pp.20826-20832, 1999.

K. Kawane, H. Fukuyama, G. Kondoh, J. Takeda, Y. Ohsawa et al., Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver, Science, vol.292, pp.1546-1549, 2001.

M. Keimpema, . Van, L. J. Grüneberg, M. Mokry, R. Boxtel et al., FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-?B to promote survival of human B cells, Blood, vol.124, pp.3431-3440, 2014.

M. G. Kemp, Z. Akan, S. Yilmaz, M. Grillo, S. L. Smith-roe et al., Tipin-Replication Protein A Interaction Mediates Chk1 Phosphorylation by ATR in Response to Genotoxic Stress, J Biol Chem, vol.285, pp.16562-16571, 2010.

S. A. Kennedy, M. L. Frazier, M. Steiniger, A. M. Mast, W. F. Marzluff et al., , 2009.

, Crystal Structure of the HEAT Domain from the Pre-mRNA Processing Factor Symplekin, J Mol Biol, vol.392, pp.115-128

G. Kerdivel, V. Chesnais, E. Becht, A. Toma, N. Cagnard et al., Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling, Leukemia, vol.32, pp.558-562, 2018.

N. Kfir, G. Lev-maor, O. Glaich, A. Alajem, A. Datta et al., , 2015.

, SF3B1 Association with Chromatin Determines Splicing Outcomes, vol.11, pp.618-629

A. R. Kim, J. C. Ulirsch, S. Wilmes, E. Unal, I. Moraga et al., Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation. Cell, vol.168, pp.1053-1064, 2017.

E. Kim, J. O. Ilagan, Y. Liang, G. M. Daubner, S. Lee et al., SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition, vol.27, pp.617-630, 2015.

P. D. Kingsley, J. Malik, K. A. Fantauzzo, and J. Palis, Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis, Blood, vol.104, pp.19-25, 2004.

P. Koch, V. Olsavszky, F. Ulbrich, C. Sticht, A. Demory et al., Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis, Blood, vol.129, pp.415-419, 2017.

J. D. Kohtz, S. F. Jamison, C. L. Will, P. Zuo, R. Lührmann et al., Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors, Nature, vol.368, pp.119-124, 1994.

A. M. Kolinjivadi, V. Sannino, A. De-antoni, K. Zadorozhny, M. Kilkenny et al., Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments, Mol. Cell, vol.67, pp.867-881, 2017.

S. Krishna, B. M. Wagener, H. P. Liu, Y. Lo, R. Sterk et al., , 2007.

K. Mre11, Regulation of Double-Strand Break Repair by Gene Conversion and Break-Induced Replication, DNA Repair (Amst), vol.6, pp.797-808

J. Krönke, E. C. Fink, P. W. Hollenbach, K. J. Macbeth, S. N. Hurst et al., Lenalidomide induces ubiquitination and degradation of CK1? in del(5q) MDS, Nature, vol.523, pp.183-188, 2015.

G. Krystal, Transforming growth factor beta 1 is an inducer of erythroid differentiation, Journal of Experimental Medicine, vol.180, pp.851-860, 1994.

A. Kumagai and W. G. Dunphy, Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts, Mol. Cell, vol.6, pp.839-849, 2000.

A. Kumagai, J. Lee, H. Y. Yoo, and W. G. Dunphy, TopBP1 activates the ATR-ATRIP complex, Cell, vol.124, pp.943-955, 2006.

C. Lacombe, J. L. Da-silva, P. Bruneval, J. G. Fournier, F. Wendling et al., Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney, J. Clin. Invest, vol.81, pp.620-623, 1988.

B. J. Lamarche, N. I. Orazio, and M. D. Weitzman, The MRN complex in Double-Strand Break Repair and Telomere Maintenance, FEBS Lett, vol.584, pp.3682-3695, 2010.

S. Lambert and B. S. Lopez, Inactivation of the RAD51 recombination pathway stimulates UV-induced mutagenesis in mammalian cells, Oncogene, vol.21, pp.4065-4069, 2002.

A. I. Lamond and D. L. Spector, Nuclear speckles: a model for nuclear organelles, Nature Reviews Molecular Cell Biology, vol.4, pp.605-612, 2003.

M. F. Lavin, S. Kozlov, M. Gatei, and A. W. Kijas, ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor, Biomolecules, vol.5, pp.2877-2902, 2015.

G. Layer, J. Reichelt, D. Jahn, and D. W. Heinz, Structure and function of enzymes in heme biosynthesis, Protein Sci, vol.19, pp.1137-1161, 2010.

L. Tallec, B. Koundrioukoff, S. Wilhelm, T. Letessier, A. Brison et al., , 2014.

, Updating the mechanisms of common fragile site instability: how to reconcile the different views?, Cell Mol Life Sci, vol.71, pp.4489-4494

S. C. Lee, .. Dvinge, H. Kim, E. Cho, H. Micol et al., Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins, Nat. Med, vol.22, pp.672-678, 2016.

T. Lefebvre, N. Dessendier, D. Houamel, N. Ialy-radio, C. Kannengiesser et al., LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders, Clinical Chemistry and Laboratory Medicine (CCLM), vol.53, pp.1557-1567, 2015.

M. J. Leimberg, E. Prus, A. M. Konijn, and E. Fibach, Macrophages function as a ferritin iron source for cultured human erythroid precursors, J. Cell. Biochem, vol.103, pp.1211-1218, 2008.

R. Leipuviene and E. C. Theil, The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen, Cell. Mol. Life Sci, vol.64, pp.2945-2955, 2007.

H. A. Leitch, Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy, Leukemia Research, vol.31, pp.7-9, 2007.

W. Y. Leong, H. D. Nguyen, W. Li, M. J. Walter, L. Zou et al., Spliceosomal Mutations Induce R Loop-Associated ATR Signaling, vol.130, pp.116-116, 2017.

X. Li and J. L. Manley, Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability, Cell, vol.122, pp.365-378, 2005.

J. Li, J. Hale, P. Bhagia, F. Xue, L. Chen et al., Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E, Blood, vol.124, pp.3636-3645, 2014.

L. Lin, Y. P. Goldberg, and T. Ganz, Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin, Blood, vol.106, pp.2884-2889, 2005.

L. Lin, E. V. Valore, E. Nemeth, J. B. Goodnough, V. Gabayan et al., Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4, Blood, vol.110, pp.2182-2189, 2007.

A. List, The Medalist Trial: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions, 2018.

A. F. List, M. R. Baer, D. P. Steensma, A. Raza, J. Esposito et al., Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion-Dependent Patients With Myelodysplastic Syndrome, JCO, vol.30, pp.2134-2139, 2012.

H. X. Liu, S. L. Chew, L. Cartegni, M. Q. Zhang, and A. R. Krainer, Exonic splicing enhancer motif recognized by human SC35 under splicing conditions, Mol. Cell. Biol, vol.20, pp.1063-1071, 2000.

Q. Liu, O. Davidoff, K. Niss, and V. H. Haase, Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis, J. Clin. Invest, vol.122, pp.4635-4644, 2012.

M. Lopes, M. Foiani, and J. M. Sogo, Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions, Mol. Cell, vol.21, pp.15-27, 2006.

G. Lossaint, M. Larroque, C. Ribeyre, N. Bec, C. Larroque et al., FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling, Mol. Cell, vol.51, pp.678-690, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00876639

M. I. Love, W. Huber, A. , and S. , Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biology, vol.15, p.550, 2014.

M. Macheret and T. D. Halazonetis, DNA replication stress as a hallmark of cancer, Annu Rev Pathol, vol.10, pp.425-448, 2015.

V. Madan, D. Kanojia, J. Li, R. Okamoto, A. Sato-otsubo et al., Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome, Nature Communications, vol.6, p.6042, 2015.

N. Mailand, S. Bekker-jensen, J. Bartek, L. , and J. , Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress, Mol. Cell, vol.23, pp.307-318, 2006.

L. Malcovati and M. Cazzola, Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts, Br. J. Haematol, vol.174, pp.847-858, 2016.

L. Malcovati, M. G. Porta, C. Pascutto, R. Invernizzi, M. Boni et al., Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making, JCO, vol.23, pp.7594-7603, 2005.

L. Malcovati, E. Papaemmanuil, D. T. Bowen, J. Boultwood, M. G. Porta et al., Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms, Blood, vol.118, pp.6239-6246, 2011.

L. Malcovati, M. Karimi, E. Papaemmanuil, I. Ambaglio, M. Jädersten et al., SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts, Blood, vol.126, pp.233-241, 2015.

D. Manwani and J. J. Bieker, The Erythroblastic Island, Curr Top Dev Biol, vol.82, pp.23-53, 2008.

M. Martin, L. Maßhöfer, P. Temming, S. Rahmann, C. Metz et al., Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nat. Genet, vol.45, pp.933-936, 2013.

S. Mathis, N. Chapuis, C. Debord, A. Rouquette, I. Radford-weiss et al., Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes, Leukemia, vol.27, pp.1981-1987, 2013.

S. Matsuoka, B. A. Ballif, A. Smogorzewska, E. R. Mcdonald, K. E. Hurov et al., ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage, Science, vol.316, pp.1160-1166, 2007.

T. W. Matthes, G. Meyer, K. Samii, and P. Beris, Increased apoptosis in acquired sideroblastic anaemia, Br. J. Haematol, vol.111, pp.843-852, 2000.

A. P. Maxwell, T. R. Lappin, C. F. Johnston, J. M. Bridges, and M. G. Mcgeown, , 1990.

, Erythropoietin production in kidney tubular cells, Br. J. Haematol, vol.74, pp.535-539

A. T. Mckie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr et al., A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation, Mol. Cell, vol.5, pp.299-309, 2000.

A. T. Mckie, D. Barrow, G. O. Latunde-dada, A. Rolfs, G. Sager et al., An iron-regulated ferric reductase associated with the absorption of dietary iron, Science, vol.291, pp.1755-1759, 2001.

M. Georgia, R. P. La, K. Christian, S. Beate, H. Dorn-beineke-alexandra et al., The soluble transferrin receptor in dysplastic erythropoiesis in myelodysplastic syndrome, European Journal of Haematology, vol.79, pp.8-16, 2007.

M. Meunier, S. Ancelet, C. Lefebvre, J. Arnaud, C. Garrel et al., Reactive oxygen species levels control NF-κB activation by low dose deferasirox in erythroid progenitors of low risk myelodysplastic syndromes, Oncotarget, vol.8, pp.105510-105524, 2017.

S. A. Mian, K. Rouault-pierre, A. E. Smith, T. Seidl, I. Pizzitola et al., SF3B1 mutant MDS-initiating cells may arise from the haematopoietic stem cell compartment, Nature Communications, vol.6, p.10004, 2015.

T. Misteli and D. L. Spector, RNA polymerase II targets pre-mRNA splicing factors to transcription sites in vivo, Mol. Cell, vol.3, pp.697-705, 1999.

I. Moraga, G. Wernig, S. Wilmes, V. Gryshkova, C. P. Richter et al., Tuning Cytokine Receptor Signaling by Re-orienting Dimer Geometry with Surrogate Ligands, Cell, vol.160, pp.1196-1208, 2015.

M. Moriel-carretero, S. Ovejero, M. Gérus-durand, D. Vryzas, and A. Constantinou, , 2017.

, Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors, J. Cell Biol, vol.216, pp.4007-4026

T. Mortera-blanco, M. Dimitriou, P. S. Woll, M. Karimi, E. Elvarsdottir et al., SF3B1-initiating mutations in MDS-RSs target lymphomyeloid hematopoietic stem cells, Blood, vol.130, pp.881-890, 2017.

M. Muckenthaler, N. K. Gray, and M. W. Hentze, IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F, Mol. Cell, vol.2, pp.383-388, 1998.

G. J. Mufti, J. M. Bennett, J. Goasguen, B. J. Bain, I. Baumann et al., Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts, Haematologica, vol.93, pp.1712-1717, 2008.

V. Munugalavadla, L. C. Dore, B. L. Tan, L. Hong, M. Vishnu et al., Repression of c-Kit and Its Downstream Substrates by GATA-1 Inhibits Cell Proliferation during Erythroid Maturation, Mol Cell Biol, vol.25, pp.6747-6759, 2005.

T. Murthy, T. Bluemn, A. K. Gupta, M. Reimer, S. Rao et al., , 2018.

, Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin, J. Biol. Chem, vol.293, pp.10220-10234

S. K. Nandakumar, J. C. Ulirsch, and V. G. Sankaran, Advances in understanding erythropoiesis: evolving perspectives, British Journal of Haematology, vol.173, pp.206-218, 2016.

E. Nemeth and T. Ganz, Regulation of Iron Metabolism by Hepcidin, Annual Review of Nutrition, vol.26, pp.323-342, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00864080

E. Nemeth, E. V. Valore, M. Territo, G. Schiller, A. Lichtenstein et al., Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein, Blood, vol.101, pp.2461-2463, 2003.

E. Nemeth, M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan et al., Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization, Science, vol.306, pp.2090-2093, 2004.

E. Nemeth, S. Rivera, V. Gabayan, C. Keller, S. Taudorf et al., , 2004.

, IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin, J Clin Invest, vol.113, pp.1271-1276

H. Neubauer, A. Cumano, M. Müller, H. Wu, U. Huffstadt et al., Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis, Cell, vol.93, pp.397-409, 1998.

J. Neukirchen, W. M. Schoonen, C. Strupp, N. Gattermann, C. Aul et al., Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDSregistry, Leuk. Res, vol.35, pp.1591-1596, 2011.

H. D. Nguyen, T. Yadav, S. Giri, B. Saez, T. A. Graubert et al., Functions of Replication Protein A as a Sensor of R Loops and a Regulator of RNaseH1, Mol. Cell, vol.65, pp.832-847, 2017.

H. D. Nguyen, W. Y. Leong, W. Li, P. N. Reddy, J. D. Sullivan et al., Spliceosome Mutations Induce R Loop-Associated Sensitivity to ATR Inhibition in Myelodysplastic Syndromes, Cancer Res, vol.78, pp.5363-5374, 2018.

G. Nicolas, M. Bennoun, I. Devaux, C. Beaumont, B. Grandchamp et al., Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice, Proc. Natl. Acad. Sci. U.S.A, vol.98, pp.8780-8785, 2001.
URL : https://hal.archives-ouvertes.fr/inserm-00331349

G. Nicolas, M. Bennoun, A. Porteu, S. Mativet, C. Beaumont et al., Severe iron deficiency anemia in transgenic mice expressing liver hepcidin, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.4596-4601, 2002.

G. Nicolas, L. Viatte, D. Lou, M. Bennoun, C. Beaumont et al., Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis, Nature Genetics, vol.34, pp.97-101, 2003.

M. Nikpour, C. Scharenberg, A. Liu, S. Conte, M. Karimi et al., The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts, Leukemia, vol.27, pp.889-896, 2013.

F. Notta, S. Zandi, N. Takayama, S. Dobson, O. I. Gan et al., Distinct routes of lineage development reshape the human blood hierarchy across ontogeny, Science, vol.351, pp.2116-2116, 2016.

E. A. Obeng, R. J. Chappell, M. Seiler, M. C. Chen, D. R. Campagna et al., Physiologic Expression of Sf3b1K700E Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation, Cancer Cell, vol.30, pp.404-417, 2016.

M. Ogawa, Y. Matsuzaki, S. Nishikawa, S. Hayashi, T. Kunisada et al., Expression and function of c-kit in hemopoietic progenitor cells, J. Exp. Med, vol.174, pp.63-71, 1991.

E. Olson, C. J. Nievera, V. Klimovich, E. Fanning, and X. Wu, RPA2 is a direct downstream target for ATR to regulate the S-phase checkpoint, J. Biol. Chem, vol.281, pp.39517-39533, 2006.

S. Omar, M. Feki, and N. Kaabachi, Le métabolisme du fer : revue générale et récents développements, Annales de Biologie Clinique, vol.64, pp.523-534, 2006.

R. Origa, R. Galanello, T. Ganz, N. Giagu, L. Maccioni et al., Liver iron concentrations and urinary hepcidin in ?-thalassemia, Haematologica, vol.92, pp.583-588, 2007.

S. H. Orkin, GATA-binding transcription factors in hematopoietic cells, Blood, vol.80, pp.575-581, 1992.

S. Osaki, D. A. Johnson, and E. Frieden, The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum, J. Biol. Chem, pp.2746-2751, 1966.

M. Pak, M. A. Lopez, V. Gabayan, T. Ganz, and S. Rivera, Suppression of hepcidin during anemia requires erythropoietic activity, Blood, vol.108, pp.3730-3735, 2006.

M. Pak, M. A. Lopez, V. Gabayan, T. Ganz, and S. Rivera, Suppression of hepcidin during anemia requires erythropoietic activity, Blood, vol.108, pp.3730-3735, 2006.

J. Palis, Primitive and definitive erythropoiesis in mammals, Front Physiol, vol.5, 2014.

J. Palis, R. J. Chan, A. Koniski, R. Patel, M. Starr et al., Spatial and temporal emergence of high proliferative potential hematopoietic precursors during murine embryogenesis, Proc Natl Acad Sci U S A, vol.98, pp.4528-4533, 2001.

Q. Pan, O. Shai, L. J. Lee, B. J. Frey, and B. J. Blencowe, Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing, Nature Genetics, vol.40, pp.1413-1415, 2008.

E. Papaemmanuil, M. Cazzola, J. Boultwood, L. Malcovati, P. Vyas et al., Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts, New England Journal of Medicine, vol.365, pp.1384-1395, 2011.

E. Papaemmanuil, M. Gerstung, L. Malcovati, S. Tauro, G. Gundem et al., Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, vol.122, pp.3616-3627, 2013.

S. Parajuli, D. C. Teasley, B. Murali, J. Jackson, A. Vindigni et al., Human ribonuclease H1 resolves R-loops and thereby enables progression of the DNA replication fork, J. Biol. Chem, vol.292, pp.15216-15224, 2017.

C. H. Park, E. V. Valore, A. J. Waring, and T. Ganz, Hepcidin, a urinary antimicrobial peptide synthesized in the liver, J. Biol. Chem, vol.276, pp.7806-7810, 2001.

S. Park, S. Grabar, C. Kelaidi, O. Beyne-rauzy, F. Picard et al., Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience, Blood, vol.111, pp.574-582, 2008.

S. Pasricha, D. M. Frazer, D. K. Bowden, A. , and G. J. , Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with ?-thalassemia major: a longitudinal study, Blood, vol.122, pp.124-133, 2013.

M. Patil, N. Pabla, D. , and Z. , Checkpoint kinase 1 in DNA damage response and cell cycle regulation, Cell Mol Life Sci, vol.70, pp.4009-4021, 2013.

R. D. Paulsen, D. V. Soni, R. Wollman, A. T. Hahn, M. Yee et al., A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability, Mol Cell, vol.35, pp.228-239, 2009.

A. Pellagatti, M. Cazzola, A. A. Giagounidis, L. Malcovati, M. G. Porta et al., Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype, Blood, vol.108, pp.337-345, 2006.

A. C. Perkins, A. H. Sharpe, and S. H. Orkin, Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF, Nature, vol.375, pp.318-322, 1995.

M. F. Perutz, X-ray analysis of hemoglobin, Science, vol.140, pp.863-869, 1963.

E. Petermann, M. L. Orta, N. Issaeva, N. Schultz, and T. Helleday, Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair, Mol. Cell, vol.37, pp.492-502, 2010.

C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin et al., A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload, J. Biol. Chem, vol.276, pp.7811-7819, 2001.

H. Pimentel, M. Parra, S. Gee, D. Ghanem, X. An et al., A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis, Nucleic Acids Res, vol.42, pp.4031-4042, 2014.

H. Pimentel, M. Parra, S. L. Gee, N. Mohandas, L. Pachter et al., A dynamic intron retention program enriched in RNA processing genes regulates gene expression during terminal erythropoiesis, Nucleic Acids Res, vol.44, pp.838-851, 2016.

U. Platzbecker, U. Germing, K. S. Götze, P. Kiewe, K. Mayer et al., Luspatercept for the treatment of anaemia in patients with lowerrisk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study, The Lancet Oncology, vol.18, pp.1338-1347, 2017.

C. Pondarré, B. B. Antiochos, D. R. Campagna, S. L. Clarke, E. L. Greer et al., The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis, Hum. Mol. Genet, vol.15, pp.953-964, 2006.

K. S. Potts, T. J. Sargeant, J. F. Markham, W. Shi, C. Biben et al., A lineage of diploid platelet-forming cells precedes polyploid megakaryocyte formation in the mouse embryo, Blood, vol.124, pp.2725-2729, 2014.

E. Prades, C. Chambon, T. A. Dailey, H. A. Dailey, J. Brière et al., A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia, Hum. Genet, vol.95, pp.424-428, 1995.

C. W. Pugh, C. C. Tan, R. W. Jones, and P. J. Ratcliffe, Functional analysis of an oxygenregulated transcriptional enhancer lying 3' to the mouse erythropoietin gene, Proc Natl Acad Sci U S A, vol.88, pp.10553-10557, 1991.

B. Qiao, P. Sugianto, E. Fung, A. Del-castillo-rueda, M. Moran-jimenez et al., Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination, Cell Metab, vol.15, pp.918-924, 2012.

V. Quesada, L. Conde, N. Villamor, G. R. Ordóñez, P. Jares et al., Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia, Nature Genetics, vol.44, pp.47-52, 2012.

G. Ramey, J. Deschemin, and S. Vaulont, Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes, Haematologica, vol.94, pp.765-772, 2009.

M. A. Reijns, B. Rabe, R. E. Rigby, P. Mill, K. R. Astell et al., Enzymatic Removal of Ribonucleotides from DNA Is Essential for Mammalian Genome Integrity and Development, Cell, vol.149, pp.1008-1022, 2012.

K. Rejeski, Y. Liang, T. Tebaldi, G. Stefani, A. Taylor et al., Integrative Genome-Wide Analysis of RNA Binding and Splicing Reveals Complex Loss and Gain of Function Alterations By SRSF2 P95 Mutations in Myelodysplasia, Blood, vol.126, pp.141-141, 2015.

I. Remy, I. A. Wilson, and S. W. Michnick, Erythropoietin receptor activation by a ligandinduced conformation change, Science, vol.283, pp.990-993, 1999.

J. Ribeil, Y. Zermati, J. Vandekerckhove, S. Cathelin, J. Kersual et al., Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1, Nature, vol.445, pp.102-105, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00092601

D. R. Richardson and P. Ponka, The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells, Biochim. Biophys. Acta, vol.1331, pp.1-40, 1997.

P. Rodriguez, E. Bonte, J. Krijgsveld, K. E. Kolodziej, B. Guyot et al., GATA-1 forms distinct activating and repressive complexes in erythroid cells, EMBO J, vol.24, pp.2354-2366, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00146853

P. Roepstorff and J. Fohlman, Proposal for a common nomenclature for sequence ions in mass spectra of peptides, Biomed. Mass Spectrom, vol.11, p.601, 1984.

T. A. Rouault, M. W. Hentze, S. W. Caughman, J. B. Harford, and R. D. Klausner, Binding of a cytosolic protein to the iron-responsive element of human ferritin messenger RNA, Science, vol.241, pp.1207-1210, 1988.

C. N. Roy and C. A. Enns, Iron homeostasis: new tales from the crypt, Blood, vol.96, pp.4020-4027, 2000.

C. E. Rübe, A. Fricke, T. A. Widmann, T. Fürst, H. Madry et al., Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging, PLoS ONE, vol.6, 2011.

S. Saleque, S. Cameron, and S. H. Orkin, The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages, Genes Dev, vol.16, pp.301-306, 2002.

V. Santini, D. Girelli, A. Sanna, N. Martinelli, L. Duca et al., Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes, PLOS ONE, vol.6, 2011.

V. Santini, A. Almeida, A. Giagounidis, S. Gröpper, A. Jonasova et al., Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents, J. Clin. Oncol, vol.34, pp.2988-2996, 2016.

A. A. Sartori, C. Lukas, J. Coates, M. Mistrik, S. Fu et al., Human CtIP promotes DNA end resection, Nature, vol.450, pp.509-514, 2007.

K. I. Savage, J. J. Gorski, E. M. Barros, G. W. Irwin, L. Manti et al., Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability, Mol. Cell, vol.54, pp.445-459, 2014.

A. L. Schade, C. , and L. , An Iron-binding Component in Human Blood Plasma, Science, vol.104, pp.340-341, 1946.

J. Schanz, H. Tüchler, F. Solé, M. Mallo, E. Luño et al., New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge, J Clin Oncol, vol.30, pp.820-829, 2012.

M. J. Schellenberg, R. A. Edwards, D. B. Ritchie, O. A. Kent, M. M. Golas et al., Crystal structure of a core spliceosomal protein interface, Proc Natl Acad Sci U S A, vol.103, pp.1266-1271, 2006.

K. Schmitz-abe, S. J. Ciesielski, P. J. Schmidt, D. R. Campagna, F. Rahimov et al., Congenital sideroblastic anemia due to mutations in the mitochondrial HSP70 homologue HSPA9, Blood, vol.126, pp.2734-2738, 2015.

R. A. Schwab, J. Nieminuszczy, F. Shah, J. Langton, D. Lopez-martinez et al., The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription, Mol. Cell, vol.60, pp.351-361, 2015.

W. Seghezzi, K. Chua, F. Shanahan, O. Gozani, R. Reed et al., Cyclin E Associates with Components of the Pre-mRNA Splicing Machinery in Mammalian Cells, Molecular and Cellular Biology, vol.18, pp.4526-4536, 1998.

M. Seiler, S. Peng, A. A. Agrawal, J. Palacino, T. Teng et al., Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types, Cell Reports, vol.23, pp.282-296, 2018.

M. Seiler, A. Yoshimi, R. Darman, B. Chan, G. Keaney et al., H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers, Nat. Med, vol.24, pp.497-504, 2018.

M. M. Seldin, S. Y. Tan, and G. W. Wong, Metabolic function of the CTRP family of hormones, Rev Endocr Metab Disord, vol.15, pp.111-123, 2014.

R. Sender, S. Fuchs, M. , and R. , Revised Estimates for the Number of Human and Bacteria Cells in the Body, PLOS Biology, vol.14, p.1002533, 2016.

G. C. Shaw, J. J. Cope, L. Li, K. Corson, C. Hersey et al., Mitoferrin is essential for erythroid iron assimilation, Nature, vol.440, pp.96-100, 2006.

Y. Shi and J. Massagué, Mechanisms of TGF-? Signaling from Cell Membrane to the Nucleus, Cell, vol.113, pp.685-700, 2003.

Y. Shiozawa, S. Sato-otsubo, A. Gallì, K. Yoshida, T. Yoshizato et al., Comprehensive Analysis of Aberrant RNA Splicing in Myelodysplastic Syndromes, Blood, vol.124, pp.826-826, 2014.

Y. Shiozawa, L. Malcovati, A. Gallì, A. Sato-otsubo, K. Kataoka et al., Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia, Nat Commun, vol.9, 2018.

R. A. Shivdasani, E. L. Mayer, and S. H. Orkin, Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL, Nature, vol.373, pp.432-434, 1995.

L. Silvestri, A. Pagani, A. Nai, I. De-domenico, J. Kaplan et al., The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin, Cell Metab, vol.8, pp.502-511, 2008.

L. Silvestri, A. Pagani, and C. Camaschella, Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis, Blood, vol.111, pp.924-931, 2008.

M. Sinha, Y. C. Jang, J. Oh, D. Khong, E. Y. Wu et al., Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle, Science, vol.344, pp.649-652, 2014.

S. So, A. J. Davis, C. , and D. J. , Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites, The Journal of Cell Biology, vol.187, pp.977-990, 2009.

M. Socolovsky, A. E. Fallon, S. Wang, C. Brugnara, and H. F. Lodish, Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bcl-X(L) induction, Cell, vol.98, pp.181-191, 1999.

J. Sollier, C. T. Stork, M. L. García-rubio, R. D. Paulsen, A. Aguilera et al., , 2014.

, Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability, Mol Cell, vol.56, pp.777-785

S. Soni, S. Bala, B. Gwynn, K. E. Sahr, L. L. Peters et al., Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion, J. Biol. Chem, vol.281, pp.20181-20189, 2006.

C. S. Sørensen, L. T. Hansen, J. Dziegielewski, R. G. Syljuåsen, C. Lundin et al., The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair, Nat. Cell Biol, vol.7, pp.195-201, 2005.

D. P. Steensma, R. Bejar, S. Jaiswal, R. C. Lindsley, M. A. Sekeres et al., Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood, vol.126, pp.9-16, 2015.

D. P. Steensma, M. B. Maris, J. Yang, W. B. Donnellan, A. M. Brunner et al., H3B-8800-G0001-101: A first in human phase I study of a splicing modulator in patients with advanced myeloid malignancies, Journal of Clinical Oncology, 2017.

O. Stehling, C. Wilbrecht, and R. Lill, Mitochondrial iron-sulfur protein biogenesis and human disease, Biochimie, vol.100, pp.61-77, 2014.

P. J. Stephens, P. S. Tarpey, H. Davies, P. Van-loo, C. Greenman et al., The landscape of cancer genes and mutational processes in breast cancer, Nature, vol.486, pp.400-404, 2012.

M. Stucki, J. A. Clapperton, D. Mohammad, M. B. Yaffe, S. J. Smerdon et al., , 2005.

, MDC1 Directly Binds Phosphorylated Histone H2AX to Regulate Cellular Responses to DNA Double-Strand Breaks, Cell, vol.123, pp.1213-1226

R. N. Suragani, S. M. Cadena, S. M. Cawley, D. Sako, D. Mitchell et al., Transforming growth factor-? superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis, Nature Medicine, vol.20, pp.408-414, 2014.

M. Suzuki, M. Kobayashi-osaki, S. Tsutsumi, X. Pan, S. Ohmori et al., GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation, Genes Cells, vol.18, pp.921-933, 2013.

S. ?vikovi?, A. Crisp, S. M. Tan-wong, T. A. Guilliam, A. J. Doherty et al., R-loop formation during S phase is restricted by PrimPol-mediated repriming, The EMBO Journal, vol.99793, 2018.

L. Swart, . De, C. Reiniers, T. Bagguley, C. Marrewijk et al., Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes, Haematologica, vol.103, pp.69-79, 2018.

R. S. Syed, S. W. Reid, C. Li, J. C. Cheetham, K. H. Aoki et al., Efficiency of signalling through cytokine receptors depends critically on receptor orientation, Nature, vol.395, pp.511-516, 1998.

S. Taketani, K. Kakimoto, H. Ueta, R. Masaki, and T. Furukawa, Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase, Blood, vol.101, pp.3274-3280, 2003.

H. Tamary, H. Shalev, G. Perez-avraham, M. Zoldan, I. Levi et al., Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I, Blood, vol.112, pp.5241-5244, 2008.

T. Tanno, N. V. Bhanu, P. A. Oneal, S. Goh, P. Staker et al., High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin, Nature Medicine, vol.13, pp.1096-1101, 2007.

T. Tanno, P. Porayette, O. Sripichai, S. Noh, C. Byrnes et al., Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells, Blood, vol.114, pp.181-186, 2009.

G. D. Te-raa, I. A. Derks, V. Navrkalova, A. Skowronska, P. D. Moerland et al., The impact of SF3B1 mutations in CLL on the DNA-damage response, Leukemia, vol.29, pp.1133-1142, 2015.

R. Tehranchi, B. Fadeel, A. Forsblom, B. Christensson, J. Samuelsson et al., Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors, Blood, vol.101, pp.1080-1086, 2003.

R. Tehranchi, R. Invernizzi, A. Grandien, B. Zhivotovsky, B. Fadeel et al., Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes, Blood, vol.106, pp.247-253, 2005.

T. Teng, J. H. Tsai, X. Puyang, M. Seiler, S. Peng et al., Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complex, Nature Communications, vol.8, p.15522, 2017.

U. Testa, E. Pelosi, and C. Peschle, The transferrin receptor, Crit Rev Oncog, vol.4, pp.241-276, 1993.

S. Thépot, R. Ben-abdelali, S. Chevret, A. Renneville, O. Beyne-rauzy et al., A randomized phase II trial of azacitidine +/-epoetin-? in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents, Haematologica, vol.101, pp.918-925, 2016.

F. Thol, S. Kade, C. Schlarmann, P. Löffeld, M. Morgan et al., Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes, Blood, vol.119, pp.3578-3584, 2012.

A. Toma, O. Kosmider, S. Chevret, J. Delaunay, A. Stamatoullas et al., Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion, Leukemia, vol.30, pp.897-905, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01321412

K. Ünsal-kaçmaz, P. D. Chastain, P. Qu, P. Minoo, M. Cordeiro-stone et al., The Human Tim/Tipin Complex Coordinates an Intra-S Checkpoint Response to UV That Slows Replication Fork Displacement, Molecular and Cellular Biology, vol.27, pp.3131-3142, 2007.

K. Uto, D. Inoue, K. Shimuta, N. Nakajo, and N. Sagata, Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism, EMBO J, vol.23, pp.3386-3396, 2004.

B. Van-handel, S. L. Prashad, N. Hassanzadeh-kiabi, A. Huang, M. Magnusson et al., The first trimester human placenta is a site for terminal maturation of primitive erythroid cells, Blood, vol.116, pp.3321-3330, 2010.

J. Vandekerckhove, J. Ribeil, Y. Zermati, C. Garrido, G. Courtois et al.,

. Hsp70 and . De, GATA-1 lors de la différenciation des globules rouges, Med Sci, vol.24, pp.37-40

B. Vogelstein, N. Papadopoulos, V. E. Velculescu, S. Zhou, L. A. Diaz et al., Cancer genome landscapes, Science, vol.339, pp.1546-1558, 2013.

M. Vokurka, J. Krijt, K. Sulc, and E. Necas, Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis, Physiol Res, vol.55, pp.667-674, 2006.

M. Vujanovic, J. Krietsch, M. C. Raso, N. Terraneo, R. Zellweger et al., Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity, Molecular Cell, vol.67, pp.882-890, 2017.

C. D. Vulpe, Y. M. Kuo, T. L. Murphy, L. Cowley, C. Askwith et al., Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse, Nat. Genet, vol.21, pp.195-199, 1999.

M. C. Wahl, C. L. Will, and R. Lührmann, The Spliceosome: Design Principles of a Dynamic RNP Machine, Cell, vol.136, pp.701-718, 2009.

D. Walter, A. Lier, A. Geiselhart, F. B. Thalheimer, S. Huntscha et al., Exit from dormancy provokes DNA-damageinduced attrition in haematopoietic stem cells, Nature, vol.520, pp.549-552, 2015.

C. Wang, K. Chua, W. Seghezzi, E. Lees, O. Gozani et al., Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis, Genes Dev, vol.12, pp.1409-1414, 1998.

C. Wang, G. Sashida, A. Saraya, R. Ishiga, S. Koide et al., Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia, Blood, vol.123, pp.3336-3343, 2014.

E. T. Wang, R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang et al., Alternative isoform regulation in human tissue transcriptomes, Nature, vol.456, pp.470-476, 2008.

G. L. Wang, B. H. Jiang, E. A. Rue, and G. L. Semenza, Hypoxia-inducible factor 1 is a basichelix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc Natl Acad Sci U S A, vol.92, pp.5510-5514, 1995.

J. Wang, Y. Takagaki, and J. L. Manley, Targeted disruption of an essential vertebrate gene: ASF/SF2 is required for cell viability, Genes Dev, vol.10, pp.2588-2599, 1996.

J. Wang, S. H. Xiao, and J. L. Manley, Genetic analysis of the SR protein ASF/SF2: interchangeability of RS domains and negative control of splicing, Genes Dev, vol.12, pp.2222-2233, 1998.

L. Wang, A. N. Brooks, J. Fan, Y. Wan, R. Gambe et al., Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia, Cancer Cell, vol.30, pp.750-763, 2016.

I. M. Ward, C. , and J. , Histone H2AX Is Phosphorylated in an ATR-dependent Manner in Response to Replicational Stress, J. Biol. Chem, vol.276, pp.47759-47762, 2001.

D. A. Weinstein, C. N. Roy, M. D. Fleming, M. F. Loda, J. I. Wolfsdorf et al., , 2002.

, Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease, Blood, vol.100, pp.3776-3781

M. J. Weiss, G. Keller, and S. H. Orkin, Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells, Genes Dev, vol.8, pp.1184-1197, 1994.

M. J. Weiss, C. Yu, and S. H. Orkin, Erythroid-cell-specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line, Mol. Cell. Biol, vol.17, pp.1642-1651, 1997.

J. J. Welch, J. A. Watts, C. R. Vakoc, Y. Yao, H. Wang et al., Global regulation of erythroid gene expression by transcription factor GATA-1, Blood, vol.104, pp.3136-3147, 2004.

I. Wetterberg, G. Baurén, and L. Wieslander, The intranuclear site of excision of each intron in Balbiani ring 3 pre-mRNA is influenced by the time remaining to transcription termination and different excision efficiencies for the various introns, RNA, vol.2, pp.641-651, 1996.

W. Roy, S. , G. , and W. , The evolution of spliceosomal introns: patterns, puzzles and progress, Nature Reviews Genetics, vol.7, pp.211-221, 2006.

D. M. Wrighting and N. C. Andrews, Interleukin-6 induces hepcidin expression through STAT3, Blood, vol.108, pp.3204-3209, 2006.

H. Wu, X. Liu, R. Jaenisch, and H. F. Lodish, Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor, Cell, vol.83, pp.59-67, 1995.

R. Yamamoto, Y. Morita, J. Ooehara, S. Hamanaka, M. Onodera et al., Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells, Cell, vol.154, pp.1112-1126, 2013.

C. Yan, R. Wan, R. Bai, G. Huang, and Y. Shi, Structure of a yeast activated spliceosome at 3.5 Å resolution, Science, vol.353, pp.904-911, 2016.

X. H. Yang, B. Shiotani, M. Classon, and L. Zou, Chk1 and Claspin potentiate PCNA ubiquitination, Genes Dev, vol.22, pp.1147-1152, 2008.

M. C. Yoder, Inducing definitive hematopoiesis in a dish, Nature Biotechnology, vol.32, pp.539-541, 2014.

H. Yoshida, K. Kawane, M. Koike, Y. Mori, Y. Uchiyama et al., , 2005.

, Phosphatidylserine-dependent engulfment by macrophages of nuclei from erythroid precursor cells, Nature, vol.437, pp.754-758

K. Yoshida, M. Sanada, Y. Shiraishi, D. Nowak, Y. Nagata et al., Frequent pathway mutations of splicing machinery in myelodysplasia, Nature, vol.478, pp.64-69, 2011.

N. Yoshizawa-sugata and H. Masai, Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint, J. Biol. Chem, vol.282, pp.2729-2740, 2007.

J. S. Yu and W. Cui, Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination, Development, vol.143, pp.3050-3060, 2016.

K. Yu, F. Chedin, C. Hsieh, T. E. Wilson, and M. R. Lieber, R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells, Nat. Immunol, vol.4, pp.442-451, 2003.

L. Zamai, P. Secchiero, S. Pierpaoli, A. Bassini, S. Papa et al., TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis, Blood, vol.95, pp.3716-3724, 2000.

R. Zellweger, D. Dalcher, K. Mutreja, M. Berti, J. A. Schmid et al., Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells, J. Cell Biol, vol.208, pp.563-579, 2015.

M. K. Zeman and K. A. Cimprich, Causes and consequences of replication stress, Nature Cell Biology, vol.16, pp.2-9, 2014.

Y. Zermati, S. Fichelson, F. Valensi, J. M. Freyssinier, P. Rouyer-fessard et al., Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors, Exp. Hematol, vol.28, pp.885-894, 2000.

Y. Zermati, C. Garrido, S. Amsellem, S. Fishelson, D. Bouscary et al., Caspase activation is required for terminal erythroid differentiation, J. Exp. Med, vol.193, pp.247-254, 2001.

X. Zhang, C. Yan, X. Zhan, L. Li, J. Lei et al., Structure of the human activated spliceosome in three conformational states, Cell Research, vol.28, pp.307-322, 2018.

B. Zhao, Y. Mei, M. J. Schipma, E. W. Roth, R. Bleher et al., Nuclear Condensation during Mouse Erythropoiesis Requires Caspase-3-Mediated Nuclear Opening, Dev. Cell, vol.36, pp.498-510, 2016.

L. Zhou, A. N. Nguyen, D. Sohal, J. Ying-ma, P. Pahanish et al., Inhibition of the TGF-receptor I kinase promotes hematopoiesis in MDS, Blood, vol.112, pp.3434-3443, 2008.

Q. Zhou, A. Derti, D. Ruddy, D. Rakiec, I. Kao et al., A Chemical Genetics Approach for the Functional Assessment of Novel Cancer Genes, Cancer Res, vol.75, pp.1949-1958, 2015.

Y. Zhu, X. Li, C. Chang, F. Xu, Q. He et al., , 2016.

, SF3B1-mutated myelodysplastic syndrome with ring sideroblasts harbors more severe iron overload and corresponding over-erythropoiesis, Leukemia Research, vol.44, pp.8-16

L. Zou and S. J. Elledge, Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes, Science, vol.300, pp.1542-1548, 2003.

L. Zou, D. Liu, and S. J. Elledge, Replication protein A-mediated recruitment and activation of Rad17 complexes, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.13827-13832, 2003.